Physician

Sunir Garg, M.D.

According to 2025 Medicare claims, Sunir Garg, M.D. (NPI: 1427056134) practices ophthalmology in the Philadelphia, PA market, with the plurality of this provider's patient population coming from Delaware, PA. This provider's primary affiliated billing organization is RETINOVITREOUS ASSOCIATES LTD (NPI: 1659326452; TIN: 231932869) and primary practice location at 18017-9412.

Garg's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,436 traditional Medicare patients, billed 57,605 HCPCS/CPT codes, and received $5,715,853 in Medicare payments. The top billing code was Q5128 (Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg). Part D data shows 793 prescription claims across 291 beneficiaries totaling $46,732 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 88 records totaling $271,394. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a higher plateau to a lower plateau, from $114,017 to $46,732. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$3.5M$7.0M2015 Medicare payment: $4,793,111 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $5,638,776 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $5,772,327 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $6,691,768 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $6,955,584 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $6,454,299 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $6,498,331 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $6,372,294 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $6,055,318 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $5,715,853 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20152,06122,981$4,793,111
20162,24726,144$5,638,776
20172,06526,430$5,772,327
20182,31232,702$6,691,768
20192,15132,978$6,955,584
20201,72729,569$6,454,299
20211,60230,139$6,498,331
20221,66235,564$6,372,294
20231,58952,554$6,055,318
20241,43657,605$5,715,853

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$57K$114K2015 Drug cost: $114,017 (USD; Tot_Drug_Cst)2016 Drug cost: $105,655 (USD; Tot_Drug_Cst)2017 Drug cost: $93,980 (USD; Tot_Drug_Cst)2018 Drug cost: $76,345 (USD; Tot_Drug_Cst)2019 Drug cost: $96,898 (USD; Tot_Drug_Cst)2020 Drug cost: $88,689 (USD; Tot_Drug_Cst)2021 Drug cost: $75,053 (USD; Tot_Drug_Cst)2022 Drug cost: $54,579 (USD; Tot_Drug_Cst)2023 Drug cost: $54,800 (USD; Tot_Drug_Cst)2024 Drug cost: $46,732 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20153541,146$114,017
20163791,174$105,655
20173641,130$93,980
20183501,074$76,345
20193611,141$96,898
2020290914$88,689
2021325912$75,053
2022285827$54,579
2023287847$54,800
2024291793$46,732

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
Q5128Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg31710,049$182
67028Injection of drug into eye6043,054$106
92012Established patient problem focused exam of visual system7141,805$73
92014Established patient complete exam of visual system1,0091,186$73
92134Imaging of retina1,3784,447$31

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate27110,840$12,409
Bromfenac SodiumBromfenac Sodium341,031$5,551
Ketorolac TromethamineKetorolac Tromethamine592,149$1,367
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat644,941$1,326
OfloxacinOfloxacin932,166$969

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.47$29,686Bausch & Lomb Americas Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.41$241,708Bayer Healthcare Pharmaceuticals Inc.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Sunir Garg, M.D.?

Tedicare shows public-source Medicare data for Sunir Garg, M.D. (NPI 1427056134), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Sunir Garg, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Sunir Garg, M.D.?

Sunir Garg, M.D. is linked to RETINOVITREOUS ASSOCIATES LTD (billing NPI 1659326452) in the available physician profile data.

Does Sunir Garg, M.D. have Open Payments data?

Sunir Garg, M.D. has 88 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.